BSEAGM/EGM6h ago · 25 Sept 2026, 11:58 am
Proceedings of 29th Annual General Meeting of the Company held on 25th September 2026.
Eris Lifesciences Ltd · 540596
✦ AI SummaryResults
Eris Lifesciences Ltd held its 29th Annual General Meeting on September 25, 2026, through video conferencing, where the company transacted four business items, including the adoption of audited financial statements, appointment of a director, ratification of cost auditors, and re-appointment of an independent director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachments (1)
📄pdf
Download →
95a96d23-7fca-4a75-98e1-04860e586166.pdf
View document text
Date:25September2026
To To
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers ExchangePlaza
DalalStreet BandraKurlaComplex
Mumbai–400001 Bandra(E)
Mumbai–400051
SecurityCode:540596 Symbol:ERIS
SUBJECT:PROCEEDINGSOF20THANNUALGENERALMEETINGOFTHECOMPANYHELDON25THSEPTEMBER
2026
DearSir/Madam,
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), it is hereby informed that the following business items were transacted at the
20thAnnualGeneralMeeting(“AGM”)oftheCompanyheldthroughVideoConferencing(“VC”)on25thSeptember2026:
1. To receive, consider and adopt the Audited Standalone Financial Statements along with Audited Consolidated
FinancialStatementsoftheCompanyfortheFinancialYearendedonMarch31,2026,andthereportsoftheBoardof
DirectorsandtheAuditorsthereon;
2. To appoint a director in place of Mr. Kaushal Kamlesh Shah (DIN: 01229038) who retires by rotation and, being
eligible,offershimselfforre-appointment;
3. ToratifytheremunerationofCostAuditorsfortheFinancialYearendingMarch31,2027;
4. Tore-appointMr.SujeshVasudevan(DIN:08240092)asanIndependentDirectoroftheCompany;
The above businesses were transacted through remote e-voting in accordance with the applicable provisions of law.
The results of the voting on the aforesaid resolutions, as required under Regulation 44(3) of the SEBI (Listing
ObligationsandDisclosureRequirements)Regulations,2015,willbedisclosedtotheStockExchangesseparately.
TheAnnualGeneralMeetingcommencedat11:00A.M.andconcludedat11:30A.M.
Kindlytakenoteoftheabove.
ForErisLifesciencesLimited
MilindTalegaonkar
CompanySecretary&ComplianceOfficer
MembershipNo:A26493